| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Potassium citrate 3g/10mL mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| kaliumcitrat 3 g brev granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| kaliumcitrat 12 g/10 ml koncentreret mikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| citronsyre + monohydrat + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 550 mg + natriumcitratdihydrat 500 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 1100 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| citronsyremonohydrat 334 mg + kaliumcitrat 1100 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| Product containing potassium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing citric acid and potassium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Potassium citrate monohydrate (substance) |
Is a |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Potassium citrate monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| Potassium citrate 12g/10mL conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely potassium citrate 540 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely potassium citrate 1.08 gram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Potassium citrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only citric acid and potassium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only potassium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only potassium citrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing citric acid and potassium citrate and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Citric acid- and potassium citrate- and sodium citrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Citric acid and potassium citrate and sodium citrate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Citric acid and potassium citrate and sodium citrate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely potassium citrate 3 gram/1 sachet granules for conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely potassium citrate 3 gram/1 sachet granules for conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
1 |
| Potassium citrate anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Potassium citrate (substance) |
Inferred relationship |
Some |
|
FHIR